The IPO Buzz: WeRide (WRD) Prices Upsized IPO at $15.50 – Low End
WeRide (WRD) of China upsized its IPO at pricing to 7.74 million American Depositary Shares – up from 6.45 million ADS in the prospectus – and priced the IPO at $15.50 – the low end of its $15.50-to-$18.50 price range – to raise $120.01 million on Thursday night, Oct. 24, 2024. WeRide’s ADS are expected to start trading today – Friday, Oct. 25, 2024 – on the NASDAQ. Each ADS represents three ordinary shares.
WeRide, an autonomous driving technology company known for its robotaxis and robobuses in China, also raised $320.5 million in a concurrent private placement on Thursday night.
Morgan Stanley, J.P. Morgan and CICC (China International Capital Corp.) were the joint book-runners.
The pricing of WeRide’s IPO on Thursday night marked the Chinese company’s third time on the IPO runway. WeRide had been set to price its IPO twice in August – and both of those efforts were postponed at the last minute.
Robert Bosch GmbH, Germany, an existing shareholder, had indicated an interest in buying up to $100 million of the ADS offered in the IPO, according to the prospectus.
Private Placement Raises $320.5 Million
In the concurrent private placement, Alliance Ventures had agreed to buy $97 million – or 30.3 percent of the $320.5 million or Class A ordinary shares offered. Alliance Ventures is the venture capital fund of the Renault Nissan Mitsubishi Alliance.
JSC International Investment Fund SPC had agreed to buy $69.5 million of ordinary shares, while Get Ride Inc. was in for $50 million, and Beijing Minghong was in for $46 million, according to the prospectus. The other indications were: Kechuangzhixing Holdings Limited, $30 million; Guangqizhixing Holdings Limited and Gac Capital International Ltd.,$20 million each, and GZJK WENYUAN Inc., $8 million.
Self-Driving Taxis from China to California
WeRide, based in Guangzhou, operates self-driving taxis and robobuses in mainland China. The Chinese company has also obtained permits to test robotaxis in California and Nevada, as well as in the United Arab Emirates and Singapore, according to the prospectus.
WeRide focused on its “firsts” and milestones in the prospectus, including:
*The only autonomous driving company in the world to obtain test permits for autonomous driving vehicles in four countries – mainland China, its home; the U.S.; the United Arab Emirates (UAE) and Singapore.
*The first autonomous driving company in the world with products operating and testing in 30 cities across seven countries.
WeRide is not profitable. The company reported a net loss that’s more than five times its revenue for the 12 months that ended June 30, 2024, according to financial statements in the prospectus.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.
Source: https://www.iposcoop.com/the-ipo-buzz-weride-wrd-prices-upsized-ipo-at-15-50-low-end/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.